Treatment with Ixmyelocel-T Shown to Improve Outcomes in Heart Failure Patients Sacramento Bee "An increasing number of patients have progressive heart failure due to dilated cardiomyopathy, even after treatment with drug therapy and surgical intervention," said Timothy Henry, MD, FSCAI, director of research and an interventional cardiologist at ... Ixmyelocel-T shows promise against progressive heart failure |
